Pharmacists in Fairport, New York


45 Pharmacists found in Fairport
female pharmacist

Mrs. Nicole Terese Siwik, PHARM.D.


Pharmacist
6600 Pittsford Palmyra Rd, Fairport, NY 14450
585-223-6480    

female pharmacist

Mrs. Patricia Ann Cicero, RPH


Pharmacist
11 Chesfield Lookout, Fairport, NY 14450
585-223-7842    

female pharmacist

Paula J Lewyckyj


Pharmacist
114 N Main St, Fairport, NY 14450
585-678-4258    



female pharmacist

Rebecca M. Belmonte


Pharmacist
1304 Fairport Rd, Fairport, NY 14450
585-377-8902    

female pharmacist

Renata St James, PHARMD


Pharmacist
6707 Pittsford Palmyra Rd, Fairport, NY 14450
585-360-1814    

male pharmacist

Dr. Richard O'brocta, PHARMD


Pharmacist - Pharmacotherapy
24 Erie Cres, Fairport, NY 14450
585-598-3700    

male pharmacist

Roderick Cardarelli, RPH


Pharmacist
5 Grimsby Gate, Fairport, NY 14450
585-421-0599    

female pharmacist

Sheri Conlon, RPH


Pharmacist
66 Delemere Blvd, Fairport, NY 14450
585-425-8141    

female pharmacist

Susan Doan


Pharmacist
6707 Pittsford Palmyra Rd, Fairport, NY 14450
585-360-1814    

male pharmacist

Thomas Sanders, RPH


Pharmacist
6600 Pittsford Palmyra Rd, Fairport, NY 14450
585-223-6480     585-223-0743

female pharmacist

Tia Lum


Pharmacist
1304 Fairport Rd, Fairport, NY 14450
585-503-8503    

male pharmacist

Dr. Trevor Robert Quackenbush, PHARMD


Pharmacist
6707 Pittsford Palmyra Rd, Fairport, NY 14450
585-360-1814    

male pharmacist

Tymothy Finger, RPH


Pharmacist
6720 Pittsford-palmyra Rd, Martins Pharmacy, Fairport, NY 14450
585-425-0010     585-223-1329


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.